CFX stock forecast
Our latest prediction for Colfax Corp.'s stock price was made on the Jan. 6, 2020 when the stock price was at 37.10$.
In the short term (2weeks), CFX's stock price should underperform the market by -3.60%. During that period the price should oscillate between -5.83% and +3.31%.
In the medium term (3months), CFX's stock price should underperform the market by -5.73%. During that period the price should oscillate between -16.97% and +9.91%.Get email alerts
Create a solid portfolio with CFX
About Colfax Corp.
Colfax Corp. operates as a diversified technology company that provides orthopedic care and fabrication technology products and services to customers. The firm operates its business through the following segments: Medical Technology; and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices with a broad range of products used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures, and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Annapolis Junction, MD.
At the moment the company generates 3460M USD in revenues.
On its last earning announcement, the company reported a loss of -3.47$ per share.
The book value per share is 27.89$
Three months stock forecastJan. 6, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|